ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the
about
Cardiac rehabilitation for people with heart disease: an overview of Cochrane systematic reviewsIvabradine as adjuvant treatment for chronic heart failureCardiac rehabilitation for people with heart disease: an overview of Cochrane systematic reviewsDigitalis for treatment of heart failure in patients in sinus rhythmReduced salt intake for heart failureIvabradine as adjuvant treatment for chronic heart failureStructured telephone support or telemonitoring programmes for patients with chronic heart failureErythropoiesis-stimulating agents for anaemia in chronic heart failure patientsDigitalis for treatment of heart failure in patients in sinus rhythmAgents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyondDepressive Symptoms among Patients with Heart Failure in Korea: An Integrative ReviewHeart Failure: Diagnosis, Management and UtilizationImpact of Aldosterone Antagonists on Sudden Cardiac Death Prevention in Heart Failure and Post-Myocardial Infarction Patients: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsMicromanaging cardiac regeneration: Targeted delivery of microRNAs for cardiac repair and regenerationAerobic Exercise and Pharmacological Therapies for Skeletal Myopathy in Heart Failure: Similarities and DifferencesEffect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trialsAcute lung failureHeart failure in the Middle EastIvabradine, coronary artery disease, and heart failure: beyond rhythm controlDeterminants of adherence to heart failure medication: a systematic literature reviewHeart Failure in ChildrenTroponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure SectionPlasma brain natriuretic peptide concentrations in patients with valvular heart diseaseHeart rate and use of beta-blockers in stable outpatients with coronary artery diseasePalliative care for those with heart failure: nurses' knowledge, attitude, and preparedness to practice.Prevalence of symptomatic heart failure with reduced and with normal ejection fraction in an elderly general population-the CARLA study.Real-time phase-contrast flow MRI of the ascending aorta and superior vena cava as a function of intrathoracic pressure (Valsalva manoeuvre).Impact of device-guided slow breathing on symptoms of chronic heart failure: a randomized, controlled feasibility study.Computational models reduce complexity and accelerate insight into cardiac signaling networksTinnitus in elderly patients and prognosis of mild-to-moderate congestive heart failure: a cross-sectional study with a long-term extension of the clinical follow-up.Strategy to recognize and initiate treatment of chronic heart failure in primary care (STRETCH): a cluster randomized trialPrimary care-based multifaceted, interdisciplinary medical educational intervention for patients with systolic heart failure: lessons learned from a cluster randomised controlled trialComputer-assisted determination of left ventricular endocardial borders reduces variability in the echocardiographic assessment of ejection fraction.Heart failure patients' perceptions and use of technology to manage disease symptomsClinical implications of chronic heart failure phenotypes defined by cluster analysis.Medication assessment tool to detect care issues from routine data: a pilot study in primary care.Short-term outcomes after hospital discharge in patients admitted with heart failure in Abeokuta, Nigeria: data from the Abeokuta Heart Failure Registry.The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial.Glutathione deficiency in cardiac patients is related to the functional status and structural cardiac abnormalities.Development of a Multi-Agent m-Health Application Based on Various Protocols for Chronic Disease Self-Management.
P2860
Q22252959-20E21F9D-A508-4655-9B08-A83A86B7C039Q24185982-53A3C8E4-985E-4781-B7AE-3F59A1F3FCEAQ24194688-6177739C-D8FB-4261-927F-083EBE3FC90DQ24194992-DF64364E-9D28-4B40-91D2-277558D3C128Q24195029-C416B605-3058-4201-97E4-087CE02E3A20Q24201614-2E9B1AF8-8F55-48DC-A0F4-B99C2A917756Q24236592-A8C2270E-EE9B-4F15-9F0D-6A932B560D90Q24241045-D961EA5C-83BD-4C68-9E0E-0B577057DD1CQ24247158-D91B3D71-7B98-4CCB-9FF5-F61E7176E27DQ24645066-C9C5AF32-CF75-4665-BD48-5774B1897C46Q26741372-45B08907-97FD-418C-A7FD-FF44FB65A2D4Q26745543-DB8BE099-8D54-4CB7-AFC1-A2FADB06D8D6Q26764927-B8C66159-3B15-4713-AA54-70382827DED1Q26765166-37A9FE86-F7D7-4771-9059-61AE2FB16346Q26767412-EE8B68A3-568D-4015-BC2D-3B1DB795AAF3Q26851606-9798B65A-9310-4968-ADC5-26EC284E3425Q26852173-1848E3C5-349E-4B48-88A2-4A02D5B6B9C8Q26865181-8F6A3C7A-B42D-4F7B-8EF3-C529D6E7272EQ26865770-849F3AB6-F0A4-4955-A2E2-11F2CDD2BDEDQ27008211-3E32E4AC-07CE-4B61-9C45-3A034C8556B0Q28078446-B2BCDABE-E68F-4CCF-84DE-02191D634396Q28269814-B04FD65D-0A3E-41A7-A9E5-C0DBBDC651D2Q28603050-A216DA51-0251-489D-8B41-28BDA0A1D1B7Q28730142-528A7E93-562F-4508-A2BE-236708927782Q30217460-A3A5177D-7252-45CB-A44B-73EBD42B1246Q30317850-4965ED7C-4C84-412C-9EC1-CCC16AB3E942Q30401738-50B90BF7-FEAB-4A2D-9691-B093737CF129Q30405473-FBC5F5AB-6489-4512-A27E-1601D4B9229FQ30428985-6A8E343D-4550-401D-8B61-2AB006B226A3Q30474748-8E3EB7E3-9227-477E-B710-3DBD8AB62A8BQ30486604-1D816BD1-F915-4168-AC07-BA5E340DEE79Q30489956-D2615EEE-B74B-43E1-967A-12D3A53272C1Q30492257-794637FE-976F-4622-A7FC-894B2B5CEB4FQ30574823-CFF21BCD-534B-4E54-8E84-AB7C925C311CQ30604593-91C35373-63F1-45E9-B87D-6848A24D83DFQ30662415-9F73C166-D324-4F1C-9BF4-F3069051737EQ30850575-44733905-77AC-40B3-A04C-BECD0AA7EBD0Q31152172-BDB591AA-0028-4ECA-8B30-D99F3AE9DF01Q33421711-E3F81A30-EEA8-4BA8-AEC1-6867DDA0BAFDQ33445942-6D98A567-63BB-435A-B274-43D1DAEF807A
P2860
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
ESC guidelines for the diagnos ...... oped in collaboration with the
@en
ESC guidelines for the diagnos ...... oped in collaboration with the
@nl
type
label
ESC guidelines for the diagnos ...... oped in collaboration with the
@en
ESC guidelines for the diagnos ...... oped in collaboration with the
@nl
prefLabel
ESC guidelines for the diagnos ...... oped in collaboration with the
@en
ESC guidelines for the diagnos ...... oped in collaboration with the
@nl
P2093
P2860
P50
P921
P1476
ESC guidelines for the diagnos ...... oped in collaboration with the
@en
P2093
Andre Keren
Anna Strömberg
Arno W Hoes
ESC Committee for Practice Guidelines (CPG)
John J V McMurray
Markku Nieminen
Philip Alexander Poole-Wilson
Silvia Giuliana Priori
P2860
P304
P356
10.1016/J.EJHEART.2008.08.005
P50
P577
2008-09-16T00:00:00Z